biotechnology

• SAC at Center of Largest-Ever Insider Trading Case

  By Bob Van Voris and Patricia Hurtado, Bloomberg  |  November 21, 2012

  Former manager charged; owner Steven Cohen implicated.

• Drug Co. Execs Accused in $1.5 Mln Insider Trading Ring

  By David Voreacos, Bloomberg  |  November 20, 2012

  FBI, SEC charged individuals working at Celgene, Sanofi and Stryker.

• Class Action Cases Divide U.S. High Court

  By Greg Stohr, Bloomberg  |  November 6, 2012

  In wake of Wal-Mart, Amgen case could erect new barrier for suits by shareholders.

• 

  Patent Litigation Has Growing Impact on Bottom Line

  By John Hintze  |  September 18, 2012

  Record number of patent suits were filed last year.

• Cyber Spies Hit 760 Companies

  By Michael Riley and John Walcott, Bloomberg  |  December 13, 2011

  China-based groups have engaged in global industrial espionage for years.

• Buybacks Surge to 4-Year High

  By Adam Haigh , Whitney Kisling  |  November 14, 2011

  Low rates and valuations drive companies; shows confidence in the exconomy.

• Week’s Bond Offerings Total $38 Bln

  By Tim Catts, Bloomberg News  |  November 11, 2011

  Busiest week for corporate issuance in five months led by Amgen.

• Amgen Plans $5 Bln Buyback

  By Meg Tirrell, Bloomberg  |  November 8, 2011

  Biotech company will hold modified Dutch auction for about 10% of its shares.

• U.S. Companies Add 110,000 Workers

  By Shobhana Chandra  |  November 2, 2011

  ADP reports promising new employment numbers for October.

• 

  Ready to Take Charge

  By Staff Writer  |  October 1, 2011

  Treasury & Risk’s 2011 picks of corporate America’s outstanding financial executives under the age of 40